SCHEMBL167913

SCHEMBL167913

O=C(CBr)c1cccc(F)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.61
CES1 P23141 2/20 0.61
PTPN1 P18031 4/20 0.59
GSK3B P49841 3/20 0.57
PARP1 P09874 1/20 0.57
KDM4E B2RXH2 3/20 0.54
MAPT P10636 3/20 0.54
HPGD P15428 3/20 0.54
HTT P42858 3/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
NPC1 O15118 2/20 0.54
LMNA P02545 2/20 0.54
TSHR P16473 2/20 0.54
ALOX12 P18054 1/20 0.54
HDAC1 Q13547 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
CTNNB1 P35222 4/20 0.50
WNT3A P56704 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29520207 1.00 CES2 (0.61) CES2CES1PTPN1GSK3BPARP1
SCHEMBL9409741 0.85 GSK3B (0.70) CES1PTPN1GSK3BKDM4EMAPT
SCHEMBL29987428 0.83 MEN1 (0.72) CES2CES1PARP1KDM4EMAPT
SCHEMBL3712920 0.82 CES2 (0.63) CES2CES1PARP1KDM4EMAPT
SCHEMBL364308 0.82 CES2 (0.63) CES2CES1PARP1KDM4EMAPT
SCHEMBL29368006 0.82 CES2 (0.63) CES2CES1PARP1KDM4EMAPT
SCHEMBL29772245 0.82 CES2 (0.63) CES2CES1PARP1KDM4EMAPT
SCHEMBL7387888 0.80 MAPT (0.52) CES2CES1PARP1KDM4EMAPT
SCHEMBL2294919 0.80 PARP1 (0.62) CES2CES1PARP1KDM4EMAPT
SCHEMBL13785097 0.80 CES2 (0.61) CES2CES1PARP1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 547 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118772148-A Imidazo [1,2-a ] pyrimidine matrine/sophoridine derivative, preparation method and application 西北农林科技大学 2024-10-15 CN claimed
CN-115925317-B Concrete apparent mass modifier attached to oily release agent and preparation method thereof 山东鲁桥建材有限公司 2024-06-04 CN claimed
CN-117264281-A Preparation method and application of modified plastic pigment 深圳力合通科技有限公司 2023-12-22 CN claimed
EP-3958980-B1 TARGETED NOVEL TRIAZOLOTHIADIAZINE DERIVATIVES FOR THE TREATMENT OF LUNG CANCER ANADOLU UNIV (TR) 2023-11-15 EP claimed
CN-115925317-A Concrete apparent quality modifier attached to oily release agent and preparation method thereof 山东鲁桥建材有限公司 2023-04-07 CN claimed
US-11322701-B2 High dielectric constant composite material and application thereof PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL (CN) 2022-05-03 US claimed
CN-114369210-A Acrylic acid modified epoxy resin, preparation method thereof, copper-free silver mirror back protective coating and preparation method thereof 天津市新丽华色材有限责任公司 2022-04-19 CN claimed
CN-111808482-A Water-based multicolor art coating with color changing along with observation angle 广东巴德士化工有限公司 2020-10-23 CN claimed
CN-110669431-B High-adhesion acid-and-alkali-resistant ceramic film coating and preparation method thereof 佛山市明朝科技开发有限公司 2020-07-28 CN claimed
US-20200106034-A1 HIGH DIELECTRIC CONSTANT COMPOSITE MATERIAL AND APPLICATION THEREOF PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL (CN) 2020-04-02 US claimed
CN-110669431-A High-adhesion acid-and-alkali-resistant ceramic film coating and preparation method thereof 佛山市明朝科技开发有限公司 2020-01-10 CN claimed
US-10185057-B2 Coated articles having abrasion resistant, glass-like coatings PPG INDUSTRIES OHIO, INC. (US) 2019-01-22 US claimed
CN-105907094-A Heat-resistant high-elasticity plastic material and preparation method thereof 金宝丽科技(苏州)有限公司 2016-08-31 CN claimed
EP-2776874-B1 COATED ARTICLES HAVING ABRASION RESISTANT, GLASS-LIKE COATINGS PPG IND OHIO INC (US) 2016-02-03 EP claimed
US-6767982-B2 REACTING IN A FIRST STAGE AN ORGANOTRICHLOROSILANE OR A MIXTURE, WATER AND AN ALCOHOL AT 0-150 DEGREES C.; HYDROGEN CHLORIDE PRODUCT REMOVED; CRUDE PRODUCT TRANSFERRED TO REACTION DISTILLATION COLUMN; BOTTOMS RECOVERED DEGUSSA AG (DE) 2004-07-27 US claimed
US-20020086907-A1 Continuous manufacturing process for organoalkoxysiloxanes DEGUSSA AG (DE) 2002-07-04 US claimed
US-20250388582-A1 NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF ILDONG PHARMACEUTICAL CO LTD (KR) 2025-12-25 US disclosed
EP-4651867-A1 BETA 2-ADRENERGIC RECEPTOR AGONISTS FOR TREATMENT OR PREVENTION OF MUSCLE WASTING Atrogi AB (SE) 2025-11-26 EP disclosed
US-4005212-A ANTIDEPRESSANT, ANOREXIGENIC, PSYCHOENERGIZING, 2-PHENYL-2,3,5,6-TETRAHYDROIMIDAZO(2,1-B)THIAZOLE RHONE-POULENC S.A. (FR) 1977-01-25 US disclosed
US-3965181-A Tricyclic pharmacological agents, intermediates and methods of making SYNTEX (U.S.A.) INC. (US) 1976-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020086907-A1 Continuous manufacturing process for organoalkoxysiloxanes MED1, C9, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 CES2 706/4885CES1 583/4885PTPN1 2168/4885
US-20250388582-A1 NOVEL BICYCLIC HETEROARYL COMPOUND AND USE THEREOF GBA1, PIKFYVE, MAN2B1 CES2 1314/4885CES1 108/4885PTPN1 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.